全文获取类型
收费全文 | 29205篇 |
免费 | 2340篇 |
国内免费 | 699篇 |
专业分类
耳鼻咽喉 | 146篇 |
儿科学 | 867篇 |
妇产科学 | 651篇 |
基础医学 | 1382篇 |
口腔科学 | 327篇 |
临床医学 | 3088篇 |
内科学 | 5489篇 |
皮肤病学 | 246篇 |
神经病学 | 1950篇 |
特种医学 | 453篇 |
外科学 | 3009篇 |
综合类 | 3899篇 |
一般理论 | 1篇 |
预防医学 | 6545篇 |
眼科学 | 222篇 |
药学 | 2519篇 |
13篇 | |
中国医学 | 186篇 |
肿瘤学 | 1251篇 |
出版年
2024年 | 67篇 |
2023年 | 586篇 |
2022年 | 1379篇 |
2021年 | 1591篇 |
2020年 | 1450篇 |
2019年 | 1152篇 |
2018年 | 1200篇 |
2017年 | 1189篇 |
2016年 | 1337篇 |
2015年 | 1200篇 |
2014年 | 2727篇 |
2013年 | 2588篇 |
2012年 | 2159篇 |
2011年 | 2272篇 |
2010年 | 1640篇 |
2009年 | 1441篇 |
2008年 | 1380篇 |
2007年 | 1321篇 |
2006年 | 1053篇 |
2005年 | 860篇 |
2004年 | 636篇 |
2003年 | 515篇 |
2002年 | 413篇 |
2001年 | 382篇 |
2000年 | 310篇 |
1999年 | 187篇 |
1998年 | 153篇 |
1997年 | 187篇 |
1996年 | 130篇 |
1995年 | 105篇 |
1994年 | 100篇 |
1993年 | 85篇 |
1992年 | 89篇 |
1991年 | 69篇 |
1990年 | 65篇 |
1989年 | 42篇 |
1988年 | 44篇 |
1987年 | 21篇 |
1986年 | 20篇 |
1985年 | 22篇 |
1984年 | 15篇 |
1983年 | 11篇 |
1982年 | 12篇 |
1981年 | 9篇 |
1980年 | 7篇 |
1979年 | 7篇 |
1978年 | 4篇 |
1977年 | 7篇 |
1976年 | 2篇 |
1906年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
31.
32.
正确编制“本年盈余与预算结余差异调节表”是公立医院执行《政府会计制度》的一大难点,现有的几种差异调节方法存在诸多不足,核算正确与否依赖会计人员的基本素质,而且工作量巨大。以财务会计与预算会计差异产生的基本原理为基础,利用计算机软件实时校验并自动登记差异,是简便、高效、准确编制“本年盈余与预算结余差异调节表”的方法,本文对此进行了举例说明。 相似文献
33.
石梅 《内蒙古医科大学学报》2022,44(5)
目的: 探讨育龄、绝经过渡期子宫肌瘤患者异常阴道出血危险因素,为异常阴道出血临床精准诊断、治疗提供理论依据。方法: 选取2017年06月—2020年06月于内蒙古医科大学附属医院住院行手术治疗的子宫肌瘤患者。实验组设为非月经期异常阴道出血的子宫肌瘤患者,对照组为无异常阴道流血子宫肌瘤患者。根据第9版教科书年龄18-43岁定为育龄组;44-54岁定为绝经过渡期组(我国妇女平均绝经年龄为49.5岁,80%在44-54岁之间〔1〕)。 应用Excel双录入,核对无误后进行统计分析。计数资料的比较用R×C列联表卡方检验、四格表卡方检验及两独立样本秩和检验。非条件Logistic回归模型用于子宫肌瘤阴道异常出血危险因素的分析,并分别得到OR值与相应95%的可信区间。在此模型中,OR值>1认为是危险因素,OR值<1认为是保护因素。统计学显著性水平设定为双侧p≤0.05,即认为差异有统计学意义。全部统计分析选用SPSS19.0软件进行统计学分析。结果:1.将与子宫肌瘤阴道异常出血相关的33项临床指标纳入单因素分析得出,月经周期异常、肌瘤位置(子宫颈肌瘤)、肌瘤直径≥9cm、血红蛋白异常、子宫内膜癌、核分裂像>5个差异有统计学意义(P≤0.05),均是子宫肌瘤阴道异常出血的危险因素;2.子宫肌瘤异常阴道出血核分裂像>5个与子宫内膜病理性改变和异常阴道出血差异有统计学意义(P=0.019)。结论:1. 子宫内膜发生病理改变是子宫肌瘤患者引起异常阴道出血的原因之一。2.月经周期异常、子宫颈肌瘤、肌瘤直径≥9cm、血红蛋白异常、子宫内膜病理改变均是子宫肌瘤阴道异常出血的危险因素;子宫肌瘤核分裂像>5个是子宫平滑肌瘤出现异常阴道出血的独立高危因素;3.子宫肌瘤核分裂像>5与阴道出血、子宫内膜病理改变有统计学意义。进行单因素分析后得知,月经周期、肌瘤位置、肌瘤大小、血红蛋白、子宫内膜病理变化均子宫肌瘤阴道异常出血的发生有关。
关键词育龄;绝经过渡期;子宫平滑肌瘤;异常阴道出血;危险因素 相似文献
34.
35.
《中国现代医生》2020,58(13):97-99+104
目的考察休克指数(shock index,SI)和舒张压(diastolic blood pressure,DBP)对女性产后出血的风险预测效果。方法选取2016年1月~2018年12月在我院行产检并分娩的320例产后出血孕妇作为研究组,另外选取同期进行正常分娩的健康孕妇240例作为对照组,比较两组患者的一般临床资料、血红蛋白(hemoglobin,Hb)、舒张压(diastolic blood pressure,DBP)、收缩压(systolic blood pressure,SBP)、心率(heart rate,HR)及休克指数(shock index,SI),并采用Ordinal逻辑回归分析各参数对产后出血的风险预警。结果两组患者在年龄、孕周、BMI及新生儿体重相比,差异无统计学意义(P0.05),而孕次相比,差异具有统计学意义(P0.05);与对照组产后24 h相比,研究组产后24 h患者的DBP、SBP及Hb均显著降低,而HR和SI显著升高(P0.05);与对照组产前相比,产后24 h患者的SBP、HR及SI显著降低(P0.05);与研究组产前相比,产后24 h患者的DBP、SBP、HR及Hb均显著降低,而SI显著升高,差异具有统计学意义(P0.05);Ordinal逻辑回归分析结果显示,休克指数和舒张压对产后出血具有预警作用(P0.05)。结论休克指数和舒张压可作为评估女性产后出血的风险预测指标,临床应密切监护。 相似文献
36.
37.
38.
Background and aimPatient decision aids for oncological treatment options, provide information on the effect on recurrence rates and/or survival benefit, and on side-effects and/or burden of different treatment options. However, often uncertainty exists around the probability estimates for recurrence/survival and side-effects which is too relevant to be ignored. Evidence is lacking on the best way to communicate these uncertainties. The aim of this study is to develop a method to incorporate uncertainties in a patient decision aid for breast cancer patients to support their decision on radiotherapy.MethodsFirstly, qualitative interviews were held with patients and health care professionals. Secondly, in the development phase, thinking aloud sessions were organized with four patients and 12 health care professionals, individual and group-wise.ResultsConsensus was reached on a pictograph illustrating the whole range of uncertainty for local recurrence risks, in combination with textual explanation that a more exact personalized risk would be given by their own physician. The pictograph consisted of 100 female icons in a 10 x 10 array. Icons with a stepwise gradient color indicated the uncertainty margin. The prevalence and severity of possible side-effects were explained using verbal labels.ConclusionsWe developed a novel way of visualizing uncertainties in recurrence rates in a patient decision aid. The effect of this way of communicating risk uncertainty is currently being tested in the BRASA study (NCT03375801). 相似文献
39.
《Journal of infection and chemotherapy》2020,26(1):23-27
IntroductionAlthough peak C-reactive protein (CRP) levels are correlated with the prognosis of some diseases, there have been no reports regarding the association between peak CRP levels and mortality in patients with bacteremia. The present study aimed to determine the association between peak CRP levels and prognosis in patients with bacteremia.MethodsThis retrospective cohort study was conducted in a single tertiary hospital and included patients with bacteremia admitted to the emergency department from November 2012 to March 2017. Cox regression analysis was performed to examine the association between peak CRP levels and 30-day mortality. We also performed propensity score adjustment using potential confounding factors.ResultsOne hundred fifty-nine patients were included in the study. Peak CRP levels were significantly higher in the β-hemolytic streptococci (P = 0.001) and Streptococcus pneumoniae (P = 0.003) groups. The C-statistic of the multivariate logistic regression model for the propensity score was 0.88. For 30-day mortality, peak CRP levels >20 mg/dL did not show significance in the Cox regression analysis (hazard ratio, 0.866; 95% confidence interval, 0.489–1.537; P = 0.62). Even after propensity score adjustment, no significance was noted (hazard ratio, 0.865; 95% confidence interval, 0.399–1.876; P = 0.71).ConclusionsPeak CRP levels were not an independent predictor of mortality in patients with bacteremia in the emergency department. Clinicians should consider that patients with extremely high peak CRP levels do not necessarily have high mortality and vice versa. 相似文献
40.
Standard cost-effectiveness models compare incremental cost increases to incremental average gains in health, commonly expressed in Quality-Adjusted Life Years (QALYs). Our research generalizes earlier models in several ways. We introduce risk aversion in Quality of Life (QoL), which leads to “willingness-to-pay” thresholds that rise with illness severity, potentially by an order of magnitude. Unlike traditional CEA analyses, which discriminate against persons with disabilities, our analysis implies that the marginal value of improving QoL rises for disabled individuals. Our model can also value the uncertain benefits of medical interventions by employing well-established analytic methods from finance. Finally, we show that traditional QALYs no longer serve as a single index of health, when consumers are risk-averse. To address this problem, we derive a generalized single-index of health outcomes—the Generalized Risk-Adjusted QALY (GRA-QALY). Earlier models of CEA that abstract from risk-aversion nest as special cases of our more general model. 相似文献